104 related articles for article (PubMed ID: 18853586)
1. Antimicrobial effects of two anaesthetic agents: dexmedetomidine and midazolam.
Ayoglu H; Kulah C; Turan I
Anaesth Intensive Care; 2008 Sep; 36(5):681-4. PubMed ID: 18853586
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antimicrobial effects of dexmedetomidine and etomidate-lipuro with those of propofol and midazolam.
Keleş GT; Kurutepe S; Tok D; Gazi H; Dinç G
Eur J Anaesthesiol; 2006 Dec; 23(12):1037-40. PubMed ID: 16824238
[TBL] [Abstract][Full Text] [Related]
3. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
4. Potent antibacterial activity of oligo-3-aminopyridine against Staphylococcus aureus and Enterococcus faecalis.
Akgul C; Kaya I
Indian J Biochem Biophys; 2004; 41(2-3):120-2. PubMed ID: 22900341
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Hirose T; Sato S; Shigeta S; Fujime M; Fujita K; Yamaguti O; Ishibashi K; Igari J; Suzutani T; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Furuya N; Murai M; Deguchi T; Ishihara S; Ooe H; Matsumoto T; Takahashi K; Nishikawa M; Naito S; Egashira T; Konishi T; Oka T; Kitamura M; Kohno S; Fukuhara Y; Hirakata Y; Kondo A; Matsuda J; Nakano M; Kamidono S; Suzuki Y; Arakawa S; Kumon H; Monden K
Jpn J Antibiot; 2005 Dec; 58(6):557-654. PubMed ID: 16521346
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of Pseudognaphalium moritzianum.
Rangel D; Garcia I; Velasco J; Buitrago D; Velazco E
Fitoterapia; 2002 Dec; 73(7-8):719-20. PubMed ID: 12490240
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
Miyazakin S; Yamaguchi K
Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
[No Abstract] [Full Text] [Related]
9. Antimicrobial activity of carbene complexes of rhodium(I) and ruthenium(II).
Cetinkaya B; Cetinkaya E; Küçükbay H; Durmaz R
Arzneimittelforschung; 1996 Aug; 46(8):821-3. PubMed ID: 9125286
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595
[TBL] [Abstract][Full Text] [Related]
11. New derivatives of benzimidazole and their antimicrobial activity.
Cetínkaya E; Alici B; Gök Y; Durmaz R; Günal S
J Chemother; 1999 Apr; 11(2):83-9. PubMed ID: 10326736
[TBL] [Abstract][Full Text] [Related]
12. Benzoxazine series of histidine kinase inhibitors as potential antimicrobial agents with activity against enterococci.
Mueller-Premru M; Zidar N; Spik VC; Krope A; Kikelj D
Chemotherapy; 2009; 55(6):414-7. PubMed ID: 19955747
[TBL] [Abstract][Full Text] [Related]
13. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
Feng P; Yu R; Xia P; Lü X; Zhu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Yamaguti O; Ishibashi K; Shigeta S; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Nishikawa M; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Takahashi K; Naito S; Egashira T; Kohno S; Miyazaki Y; Hirakata Y; Aoki S
Jpn J Antibiot; 2004 Aug; 57(4):311-403. PubMed ID: 15535040
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996), III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Mar; 51(3):143-236. PubMed ID: 9597551
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activities of some tetrahydronaphthalene-benzimidazole derivatives.
Ates-Alagoz Z; Yildiz S; Buyukbingol E
Chemotherapy; 2007; 53(2):110-3. PubMed ID: 17310118
[TBL] [Abstract][Full Text] [Related]
18. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of silver and gold in toothpastes: A comparative analysis.
Junevičius J; Žilinskas J; Česaitis K; Česaitienė G; Gleiznys D; Maželienė Ž
Stomatologija; 2015; 17(1):9-12. PubMed ID: 26183852
[TBL] [Abstract][Full Text] [Related]
20. Minimum bactericidal concentrations in conventional and two other techniques.
Rahman M
J Antimicrob Chemother; 1981 Dec; 8(6):500-2. PubMed ID: 6801004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
